RXD vs. XTJL

Last updated Jun 26, 2026

RXD (ProShares UltraShort Health Care) and XTJL (Innovator U.S. Equity Accelerated Plus ETF - July) are both Leveraged Equities funds. RXD is passively managed, while XTJL is actively managed. Over the past 3 years, RXD returned -8.16%/yr vs 14.42%/yr for XTJL. At a correlation of -0.58, they often move in opposite directions. RXD charges 0.95%/yr vs 0.79%/yr for XTJL.

Performance

RXD vs. XTJL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ProShares UltraShort Health Care (RXD) and Innovator U.S. Equity Accelerated Plus ETF - July (XTJL). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, RXD achieves a -1.40% return, which is significantly lower than XTJL's 5.63% return.

RXD

• 1D: -3.08%
• 1M: -9.66%
• YTD: -1.40%
• 6M: 0.04%
• 1Y: -25.85%
• 3Y*: -8.16%
• 5Y*: -7.55%
• 10Y*: -20.50%

XTJL

• 1D: 0.02%
• 1M: 0.38%
• YTD: 5.63%
• 6M: 5.29%
• 1Y: 14.32%
• 3Y*: 14.42%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

RXD vs. XTJL - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
RXD ProShares UltraShort Health Care	-1.40%	-21.66%	4.83%	3.25%	1.20%	-20.03%
XTJL Innovator U.S. Equity Accelerated Plus ETF - July	5.63%	15.42%	14.43%	25.72%	-15.66%	7.81%

Correlation

The correlation between RXD and XTJL is -0.31, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	-0.31
Correlation (3Y) Calculated over the trailing 3-year period	-0.45
Correlation (All Time) Calculated using the full available price history since Jul 1, 2021	-0.58

Over the past year, the inverse relationship between RXD and XTJL has weakened: their correlation has moved from -0.58 to -0.31, meaning they move in opposite directions less often than they have historically.

Return for Risk

RXD vs. XTJL — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RXD

RXD Risk / Return Rank: 3
RXD Sharpe Ratio Rank: 3
RXD Sortino Ratio Rank: 3
RXD Omega Ratio Rank: 3
RXD Calmar Ratio Rank: 3
RXD Martin Ratio Rank: 4

XTJL

XTJL Risk / Return Rank: 76
XTJL Sharpe Ratio Rank: 69
XTJL Sortino Ratio Rank: 75
XTJL Omega Ratio Rank: 83
XTJL Calmar Ratio Rank: 65
XTJL Martin Ratio Rank: 86

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

RXD vs. XTJL - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ProShares UltraShort Health Care (RXD) and Innovator U.S. Equity Accelerated Plus ETF - July (XTJL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	RXD	XTJL	Difference
Sharpe ratio: Return per unit of total volatility	-0.86	1.96	-2.81
Sortino ratio: Return per unit of downside risk	-1.07	2.92	-3.99
Omega ratio: Gain probability vs. loss probability	0.87	1.44	-0.56
Calmar ratio: Return relative to maximum drawdown	-0.75	2.81	-3.56
Martin ratio: Return relative to average drawdown	-1.12	15.91	-17.03

RXD vs. XTJL - Sharpe Ratio Comparison

The current RXD Sharpe Ratio is -0.86, which is lower than the XTJL Sharpe Ratio of 1.96. The chart below compares the historical Sharpe Ratios of RXD and XTJL, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

RXD vs. XTJL - Drawdown Comparison

The maximum RXD drawdown since its inception was -99.65%, which is greater than XTJL's maximum drawdown of -23.24%. Use the drawdown chart below to compare losses from any high point for RXD and XTJL.

Drawdown Indicators

	RXD	XTJL	Difference
Max Drawdown Largest peak-to-trough decline	-99.65%	-23.24%	-76.41%
Max Drawdown (1Y) Largest decline over 1 year	-34.63%	-5.12%	-29.51%
Max Drawdown (3Y) Largest decline over 3 years	-36.60%	-16.70%	-19.90%
Max Drawdown (5Y) Largest decline over 5 years	-40.50%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-90.64%	—	—
Current Drawdown Current decline from peak	-99.63%	-0.04%	-99.59%
Average Drawdown Average peak-to-trough decline	-81.91%	-3.99%	-77.92%
Ulcer Index Depth and duration of drawdowns from previous peaks	23.10%	0.90%	+22.20%

Volatility

RXD vs. XTJL - Volatility Comparison

ProShares UltraShort Health Care (RXD) has a higher volatility of 10.55% compared to Innovator U.S. Equity Accelerated Plus ETF - July (XTJL) at 0.34%. This indicates that RXD's price experiences larger fluctuations and is considered to be riskier than XTJL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	RXD	XTJL	Difference
Volatility (1M) Calculated over the trailing 1-month period	10.55%	0.34%	+10.21%
Volatility (6M) Calculated over the trailing 6-month period	21.92%	5.61%	+16.31%
Volatility (1Y) Calculated over the trailing 1-year period	30.33%	7.35%	+22.98%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	29.91%	15.12%	+14.79%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	33.01%	15.12%	+17.89%

RXD vs. XTJL - Expense Ratio Comparison

RXD has a 0.95% expense ratio, which is higher than XTJL's 0.79% expense ratio.

Dividends

RXD vs. XTJL - Dividend Comparison

RXD's dividend yield for the trailing twelve months is around 3.01%, while XTJL has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018
RXD ProShares UltraShort Health Care	3.01%	3.29%	4.36%	3.17%	0.67%	0.00%	0.17%	1.73%	0.22%
XTJL Innovator U.S. Equity Accelerated Plus ETF - July	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both RXD and XTJL in my portfolio?

RXD and XTJL have a correlation of -0.31, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, RXD or XTJL?

RXD has higher volatility (10.55%) compared to XTJL (0.34%). In terms of maximum drawdown, RXD dropped -99.65% vs XTJL's -23.24%.

Which ETF is better, RXD or XTJL?

On 3-year performance, XTJL leads with 14.42% vs -8.16% for RXD. On fees, XTJL is cheaper at 0.79% per year. On volatility, XTJL has been the lower-risk option at 0.34%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, RXD or XTJL?

Over the 3-year period, XTJL has performed better with a 14.42% return vs -8.16%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, RXD or XTJL?

XTJL is cheaper with a 0.79% expense ratio, compared with 0.95% for RXD.

Which ETF pays a higher dividend yield, RXD or XTJL?

RXD has the higher dividend yield at 3.01%, compared with 0.00% for XTJL.

What is the main difference between RXD and XTJL?

They also come from different issuers: ProShares and Innovator. Their fees differ too: 0.95% for RXD and 0.79% for XTJL.

Which has better risk-adjusted returns?

XTJL currently has the higher Sharpe Ratio (1.96 vs -0.86), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.